Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer

Yusuke Takahashi, Yotaro Izumi, Noriyuki Matsutani, Hitoshi Dejima, Takashi Nakayama, Ryo Okamura, Hirofumi Uehara, Masafumi Kawamura

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Cryosurgery has reemerged as a less invasive local treatment with possible immune-regulatory effects. However, the optimal magnitude of cryosurgery for achieving immune-regulatory responses at abscopal tumor sites remains unclear. We aimed to investigate appropriate magnitude of cryosurgery for this goal using a mouse model. Methods: C57BL/6J mice were inoculated with Lewis lung carcinoma cells or B16 melanoma cells in bilateral flanks. The left-sided tumor was cryoablated with repeated freeze/thaw cycles either once, twice, or thrice. The peritumoral injections of LPS were performed. Abscopal tumor volumes were measured, immunohistochemistry was performed for CD4, CD8, Foxp3, and Ki-67, and proinflammatory cytokines were measured in lavage fluid of cryoablated tumor. Results: The growth rate of the abscopal tumor was slowest in the Cryosurgery ×2 group among the five experimental groups. The proportions of CD4+ T cells and CD8+ T cells in the abscopal tumor were also significantly higher in the Cryosurgery ×2 group. The levels of IL-1β, IL-2, IL-6, IL-12β, IFN-γ, and TNF-α in the peritumoral lavage fluid in Cryosurgery ×2 + LPS group were significantly increased compared with the other groups. Conclusions: This study suggested that achievement of approximately 73 % damaged area in the cryoablated tumor by two cycles of cryosurgery generates the most favorable immune-regulatory response for abscopal tumors via activation of anti-tumor immune cells as well as increased secretion of proinflammatory cytokines.

Original languageEnglish
Pages (from-to)973-982
Number of pages10
JournalCancer Immunology, Immunotherapy
Volume65
Issue number8
DOIs
Publication statusPublished - 2016 Aug 1
Externally publishedYes

Fingerprint

Cryosurgery
Lung Neoplasms
Neoplasms
Therapeutic Irrigation
Cytokines
Lewis Lung Carcinoma
T-Lymphocytes
Experimental Melanomas
Interleukin-12
Tumor Burden
Interleukin-1
Inbred C57BL Mouse
Interleukin-2
Interleukin-6
Immunohistochemistry
Injections
Growth

Keywords

  • Cryotherapy
  • Cytokine
  • Immune-reaction
  • Lung cancer
  • Tumor-infiltrating lymphocyte

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Cite this

Takahashi, Y., Izumi, Y., Matsutani, N., Dejima, H., Nakayama, T., Okamura, R., ... Kawamura, M. (2016). Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer. Cancer Immunology, Immunotherapy, 65(8), 973-982. https://doi.org/10.1007/s00262-016-1858-x

Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer. / Takahashi, Yusuke; Izumi, Yotaro; Matsutani, Noriyuki; Dejima, Hitoshi; Nakayama, Takashi; Okamura, Ryo; Uehara, Hirofumi; Kawamura, Masafumi.

In: Cancer Immunology, Immunotherapy, Vol. 65, No. 8, 01.08.2016, p. 973-982.

Research output: Contribution to journalArticle

Takahashi, Y, Izumi, Y, Matsutani, N, Dejima, H, Nakayama, T, Okamura, R, Uehara, H & Kawamura, M 2016, 'Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer', Cancer Immunology, Immunotherapy, vol. 65, no. 8, pp. 973-982. https://doi.org/10.1007/s00262-016-1858-x
Takahashi, Yusuke ; Izumi, Yotaro ; Matsutani, Noriyuki ; Dejima, Hitoshi ; Nakayama, Takashi ; Okamura, Ryo ; Uehara, Hirofumi ; Kawamura, Masafumi. / Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer. In: Cancer Immunology, Immunotherapy. 2016 ; Vol. 65, No. 8. pp. 973-982.
@article{4725c6316a3848549a60824960c93306,
title = "Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer",
abstract = "Background: Cryosurgery has reemerged as a less invasive local treatment with possible immune-regulatory effects. However, the optimal magnitude of cryosurgery for achieving immune-regulatory responses at abscopal tumor sites remains unclear. We aimed to investigate appropriate magnitude of cryosurgery for this goal using a mouse model. Methods: C57BL/6J mice were inoculated with Lewis lung carcinoma cells or B16 melanoma cells in bilateral flanks. The left-sided tumor was cryoablated with repeated freeze/thaw cycles either once, twice, or thrice. The peritumoral injections of LPS were performed. Abscopal tumor volumes were measured, immunohistochemistry was performed for CD4, CD8, Foxp3, and Ki-67, and proinflammatory cytokines were measured in lavage fluid of cryoablated tumor. Results: The growth rate of the abscopal tumor was slowest in the Cryosurgery ×2 group among the five experimental groups. The proportions of CD4+ T cells and CD8+ T cells in the abscopal tumor were also significantly higher in the Cryosurgery ×2 group. The levels of IL-1β, IL-2, IL-6, IL-12β, IFN-γ, and TNF-α in the peritumoral lavage fluid in Cryosurgery ×2 + LPS group were significantly increased compared with the other groups. Conclusions: This study suggested that achievement of approximately 73 {\%} damaged area in the cryoablated tumor by two cycles of cryosurgery generates the most favorable immune-regulatory response for abscopal tumors via activation of anti-tumor immune cells as well as increased secretion of proinflammatory cytokines.",
keywords = "Cryotherapy, Cytokine, Immune-reaction, Lung cancer, Tumor-infiltrating lymphocyte",
author = "Yusuke Takahashi and Yotaro Izumi and Noriyuki Matsutani and Hitoshi Dejima and Takashi Nakayama and Ryo Okamura and Hirofumi Uehara and Masafumi Kawamura",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s00262-016-1858-x",
language = "English",
volume = "65",
pages = "973--982",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "8",

}

TY - JOUR

T1 - Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer

AU - Takahashi, Yusuke

AU - Izumi, Yotaro

AU - Matsutani, Noriyuki

AU - Dejima, Hitoshi

AU - Nakayama, Takashi

AU - Okamura, Ryo

AU - Uehara, Hirofumi

AU - Kawamura, Masafumi

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Background: Cryosurgery has reemerged as a less invasive local treatment with possible immune-regulatory effects. However, the optimal magnitude of cryosurgery for achieving immune-regulatory responses at abscopal tumor sites remains unclear. We aimed to investigate appropriate magnitude of cryosurgery for this goal using a mouse model. Methods: C57BL/6J mice were inoculated with Lewis lung carcinoma cells or B16 melanoma cells in bilateral flanks. The left-sided tumor was cryoablated with repeated freeze/thaw cycles either once, twice, or thrice. The peritumoral injections of LPS were performed. Abscopal tumor volumes were measured, immunohistochemistry was performed for CD4, CD8, Foxp3, and Ki-67, and proinflammatory cytokines were measured in lavage fluid of cryoablated tumor. Results: The growth rate of the abscopal tumor was slowest in the Cryosurgery ×2 group among the five experimental groups. The proportions of CD4+ T cells and CD8+ T cells in the abscopal tumor were also significantly higher in the Cryosurgery ×2 group. The levels of IL-1β, IL-2, IL-6, IL-12β, IFN-γ, and TNF-α in the peritumoral lavage fluid in Cryosurgery ×2 + LPS group were significantly increased compared with the other groups. Conclusions: This study suggested that achievement of approximately 73 % damaged area in the cryoablated tumor by two cycles of cryosurgery generates the most favorable immune-regulatory response for abscopal tumors via activation of anti-tumor immune cells as well as increased secretion of proinflammatory cytokines.

AB - Background: Cryosurgery has reemerged as a less invasive local treatment with possible immune-regulatory effects. However, the optimal magnitude of cryosurgery for achieving immune-regulatory responses at abscopal tumor sites remains unclear. We aimed to investigate appropriate magnitude of cryosurgery for this goal using a mouse model. Methods: C57BL/6J mice were inoculated with Lewis lung carcinoma cells or B16 melanoma cells in bilateral flanks. The left-sided tumor was cryoablated with repeated freeze/thaw cycles either once, twice, or thrice. The peritumoral injections of LPS were performed. Abscopal tumor volumes were measured, immunohistochemistry was performed for CD4, CD8, Foxp3, and Ki-67, and proinflammatory cytokines were measured in lavage fluid of cryoablated tumor. Results: The growth rate of the abscopal tumor was slowest in the Cryosurgery ×2 group among the five experimental groups. The proportions of CD4+ T cells and CD8+ T cells in the abscopal tumor were also significantly higher in the Cryosurgery ×2 group. The levels of IL-1β, IL-2, IL-6, IL-12β, IFN-γ, and TNF-α in the peritumoral lavage fluid in Cryosurgery ×2 + LPS group were significantly increased compared with the other groups. Conclusions: This study suggested that achievement of approximately 73 % damaged area in the cryoablated tumor by two cycles of cryosurgery generates the most favorable immune-regulatory response for abscopal tumors via activation of anti-tumor immune cells as well as increased secretion of proinflammatory cytokines.

KW - Cryotherapy

KW - Cytokine

KW - Immune-reaction

KW - Lung cancer

KW - Tumor-infiltrating lymphocyte

UR - http://www.scopus.com/inward/record.url?scp=84975137943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975137943&partnerID=8YFLogxK

U2 - 10.1007/s00262-016-1858-x

DO - 10.1007/s00262-016-1858-x

M3 - Article

VL - 65

SP - 973

EP - 982

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 8

ER -